Stock Scorecard
Stock Summary for Inmode Ltd (INMD) - $17.02 as of 4/25/2024 8:23:43 PM EST
Total Score
20 out of 29
Currently on the following lists
Growth Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for INMD
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INMD
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INMD
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for INMD
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for INMD
Financial Details for INMD
Company Overview |
|
---|---|
Ticker | INMD |
Company Name | Inmode Ltd |
Country | USA |
Description | InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/2/2024 |
Stock Price History |
|
Last Day Price | 17.02 |
Last Day Price Updated | 4/25/2024 8:23:43 PM EST |
Last Day Volume | 946,581 |
Average Daily Volume | 1,437,002 |
52-Week High | 48.25 |
52-Week Low | 16.96 |
Last Price to 52 Week Low | 0.35% |
Valuation Measures |
|
Trailing PE | 7.55 |
Industry PE | 47.62 |
Sector PE | 61.73 |
5-Year Average PE | 16.04 |
Free Cash Flow Ratio | 9.95 |
Industry Free Cash Flow Ratio | 21.57 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 13.18 |
Total Cash Per Share | 1.71 |
Book Value Per Share Most Recent Quarter | 9.38 |
Price to Book Ratio | 1.93 |
Industry Price to Book Ratio | 3.23 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 3.08 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.52 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 84,619,000 |
Market Capitalization | 1,440,215,380 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 44.50% |
Annual Earnings Growth | 22.54% |
Reported EPS 12 Trailing Months | 2.30 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 2.56 |
Net Income Twelve Trailing Months | 197,919,000 |
Net Income Past Year | 197,919,000 |
Net Income Prior Year | 161,520,000 |
Quarterly Revenue Growth YOY | -5.10% |
5-Year Revenue Growth | 37.49% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 144,411,000 |
Total Cash Past Year | 144,411,000 |
Total Cash Prior Year | 97,540,000 |
Net Cash Position Most Recent Quarter | 144,411,000 |
Net Cash Position Past Year | 144,411,000 |
Long Term Debt Past Year | 0 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 0 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 787,372,000 |
Total Stockholder Equity Prior Year | 554,618,000 |
Total Stockholder Equity Most Recent Quarter | 787,372,000 |
Options |
|
Put/Call Ratio | 0.27 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -1.09 |
MACD Signal | -0.96 |
20-Day Bollinger Lower Band | 17.16 |
20-Day Bollinger Middle Band | 21.47 |
20-Day Bollinger Upper Band | 25.78 |
Beta | 2.16 |
RSI | 34.57 |
50-Day SMA | 28.27 |
200-Day SMA | 35.82 |
System |
|
Modified | 4/25/2024 3:21:15 AM EST |